chemo drugs Flashcards
alkylating agents
nitrogen mustards mehtyhydrazine derivative alkyl sulfonate nitrosoureas triazenes platinum coordination complexes not cell cycle specific
nitrogen mustards
cyclophosphamide
ifosfamide
alkyl suflonate
busulfan
platinum coordination complexes
cisplatin
antimetabolites
Folic acid analogs
pyrimidine analogs
purine analogs
cell cycle specific (S)
folic acid analogs
methotrexate (MTX)
pyrimidine analogs
fluorouracil (5-FU)
purine analogs
mercaptopurine (6-MP_
natural products
vinca alkaloids taxanes epipofophyllotoxins camptothecins antibiotics echionocandins anthracenedione enzymes
vinca alkaloids
vineblastine
vincristine
taxanes
paclitaxel
epipodophyollotoxins
etopodise
antibiotics
doxorubicin
anthracenedione
bleomycin
enzymes
L-asparaginase
proteins tyrosine kinase inhibitos
Imatinib
all end in tinib
monoclonal Abs
trastuxumab
rescue agents
leucovorin
Mesna
agents to minimize adverse effects
filgrastim and pegfilgrastin
erythopoietin
ondansetron (serotonin antagonist)
primary induction chemo
Tx for advanced stage with no other alternative
Neoadjuvant chemotherapy
localized cancer for which surgery or radiation are not effective
adjuvant chemo
reduce incidence of both local and systemic recurrence and increase overall survival
Cell cycle
G0 -> G1 -> S -> G2 -> M
G1
preceded DNA synthesis
synthesis of DNA componenets
S
DNA synthesase
G2
synthesis of components for division
M
mitosis
divides into 2 cells which can enter G1 or G0
intermittent high dose therapy
most common
better for phase non-specific
continuous effusion
drugs that are rapidly metabolised and/or excreted
better for cell cycle specific
resistance pathways
decreased drug transport into cells
reduced drug affinity due to mutations of drug target
increased expression of enzymes that inactivate drug
increased expression of DNA repair enzymes
multidrug resistance
MDR1 gene -> P-glycoprotein -> pumps (ATP dependent) drug out of tumor cells
may be inhibited by CaCh blocers (verapamil)
highly dividing cells at high risk for toxicity
bone marrow FI tract hair folicles buccal mucosa sperm forming cells
nadir
blood count low point due to cehmo
usually 10-14 days after Tx and recover in 21-28 days
sargramostim
GM-CSF to stimulate WBC proliferation